Department of Bioengineering and Therapeutic Sciences

Researchers in the laboratory of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, study the roles of gene regulatory elements—DNA segments that tell genes when, where, and to what extent to turn on and off—including in human conditions ranging from limb malformations to epilepsy and autism.

The statutory requirement for substantial evidence of effectiveness of a new drug has generally been interpreted to require demonstration of a low probability (p<0.05), assuming non-effectiveness, based on data from two phase III clinical trials.

UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI).

The UCSF School of Pharmacy’s doctor of pharmacy (PharmD) program is among the top-ranked programs in the 2017 U.S. News and World Report survey of accredited PharmD programs released on March 15, 2016.

A five-day fundamentals course emphasizing basic principles in pharmacokinetics. This is an annual course now in its 29th year.